Yves Luisser

Biography

Dr. Lussier is an international expert in translational bioinformatics and a pioneer in research informatics techniques including systems biology, data representation through ontologies and high-throughput methods in personalized medicine. At the University of Arizona, he serves as professor of medicine, associate vice president for health sciences and chief knowledge officer for AHSC; associate director for cancer informatics and precision health for the University of Arizona Cancer Center; and associate director, BIO5 informatics, for the UA BIO5 Institute. He lead efforts to fully develop novel programs in biomedical informatics, computational genomics and precision health. Previously, Dr. Lussier served at the University of Illinois at Chicago (UIC), where he was professor of medicine, bioengineering and biopharmaceutical sciences, and assistant vice president for health affairs and chief research information officer for the University of Illinois Hospital and Health Sciences System. Prior to his tenure at UIC, Dr. Lussier was associate director of informatics for the University of Chicago Comprehensive Cancer Center as well as co-director of biomedical informatics for the Clinical and Translational Science Award (CTSA)-funded Institute for Translational Medicine (2006-2011). From 2001-2006, Dr. Lussier was an assistant professor in the Departments of Biomedical Informatics and Medicine at Columbia University in New York.

Research Interest

Dr. Lussier’s research interests focus on the use of ontologies, knowledge technologies and genomic network model to accurately individualize the treatment of disease and to repurpose therapies. He has National Institutes of Health funding for a clinical trial that repositioned a combination therapy, he also bioinformatically predicted and obtained biological confirmation of several novel tumor suppressor microRNAs, including the first one underpinning the oligo- vs poly- metastasis development of cancer. His research has been featured in the New York Times and the Wall Street Journal. He has authored 130 publications and delivered more than 100 invited presentations in precision medicine, systems medicine and translational bioinformatics, including 14 opening conference keynotes.